Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
basic mechanisms and clinical applications American Academy of Anti-Aging Medicine Thymosin beta 4 (Tb4) professional monograph (indications, dosage) Bachem Technical Note Peptide stability and handling guidelines International Journal of Clinical Pharmacy (2013) Evaluation of maximum beyond-use-date stability of peptide solutions CDC Vaccine administration: subcutaneous route (angle, site rotation guidance) WADA Prohibited List (2024) Growth factors and peptides prohibited in sport Arthroscopy (2025) Emerging use of BPC-157 in orthopaedic sports medicine: a systematic review PubMed (2010) Randomized, placebo-controlled, single and multiple dose study of intravenous thymosin beta4 in healthy volunteers CDC (Subcut Injection PDF) Technique diagram and site guidance for subcutaneous injections NCBI Bookshelf Administration of parenteral medications: best practices Additional Research and Background These sources provide related context and are not presented as support for a specific statement above
Brand Transparency Trustworthy companies provide clear ingredient sourcing, scientific references and manufacturing location details
Compounded medications are custom-prepared and not reviewed by the FDA
Berberian sources only pharmaceutical-grade Epithalon from carefully vetted, quality-controlled laboratories to ensure patient safety and treatment efficacy
BPC-157 10MG Common Reconstitution Reference Vial size: 10 mg Common educational reference: Add 3.0 mL bacteriostatic water Final concentration: ~3.33 mg/mL 1 unit on U-100 syringe: ~33.3 mcg Common educational reference range: 200600 mcg daily with gradual titration That same style of protocol math is commonly shown in third-party educational references for BPC-157 10MG
Bull Exp Biol Med 2003;135:4958
US$ 28.79
US$ 23.47
US$ 26.90
US$ 29.56
